Cargando…
Correction to: Designing optimized drug candidates with Generative Adversarial Network
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367066/ https://www.ncbi.nlm.nih.gov/pubmed/35953869 http://dx.doi.org/10.1186/s13321-022-00631-6 |
_version_ | 1784765706870456320 |
---|---|
author | Abbasi, Maryam Santos, Beatriz P. Pereira, Tiago C. Sofa, Raul Monteiro, Nelson R. C. Simões, Carlos J. V. Brito, Rui M. M. Ribeiro, Bernardete Oliveira, José L. Arrais, Joel P. |
author_facet | Abbasi, Maryam Santos, Beatriz P. Pereira, Tiago C. Sofa, Raul Monteiro, Nelson R. C. Simões, Carlos J. V. Brito, Rui M. M. Ribeiro, Bernardete Oliveira, José L. Arrais, Joel P. |
author_sort | Abbasi, Maryam |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9367066 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-93670662022-08-12 Correction to: Designing optimized drug candidates with Generative Adversarial Network Abbasi, Maryam Santos, Beatriz P. Pereira, Tiago C. Sofa, Raul Monteiro, Nelson R. C. Simões, Carlos J. V. Brito, Rui M. M. Ribeiro, Bernardete Oliveira, José L. Arrais, Joel P. J Cheminform Correction Springer International Publishing 2022-08-11 /pmc/articles/PMC9367066/ /pubmed/35953869 http://dx.doi.org/10.1186/s13321-022-00631-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Abbasi, Maryam Santos, Beatriz P. Pereira, Tiago C. Sofa, Raul Monteiro, Nelson R. C. Simões, Carlos J. V. Brito, Rui M. M. Ribeiro, Bernardete Oliveira, José L. Arrais, Joel P. Correction to: Designing optimized drug candidates with Generative Adversarial Network |
title | Correction to: Designing optimized drug candidates with Generative Adversarial Network |
title_full | Correction to: Designing optimized drug candidates with Generative Adversarial Network |
title_fullStr | Correction to: Designing optimized drug candidates with Generative Adversarial Network |
title_full_unstemmed | Correction to: Designing optimized drug candidates with Generative Adversarial Network |
title_short | Correction to: Designing optimized drug candidates with Generative Adversarial Network |
title_sort | correction to: designing optimized drug candidates with generative adversarial network |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367066/ https://www.ncbi.nlm.nih.gov/pubmed/35953869 http://dx.doi.org/10.1186/s13321-022-00631-6 |
work_keys_str_mv | AT abbasimaryam correctiontodesigningoptimizeddrugcandidateswithgenerativeadversarialnetwork AT santosbeatrizp correctiontodesigningoptimizeddrugcandidateswithgenerativeadversarialnetwork AT pereiratiagoc correctiontodesigningoptimizeddrugcandidateswithgenerativeadversarialnetwork AT sofaraul correctiontodesigningoptimizeddrugcandidateswithgenerativeadversarialnetwork AT monteironelsonrc correctiontodesigningoptimizeddrugcandidateswithgenerativeadversarialnetwork AT simoescarlosjv correctiontodesigningoptimizeddrugcandidateswithgenerativeadversarialnetwork AT britoruimm correctiontodesigningoptimizeddrugcandidateswithgenerativeadversarialnetwork AT ribeirobernardete correctiontodesigningoptimizeddrugcandidateswithgenerativeadversarialnetwork AT oliveirajosel correctiontodesigningoptimizeddrugcandidateswithgenerativeadversarialnetwork AT arraisjoelp correctiontodesigningoptimizeddrugcandidateswithgenerativeadversarialnetwork |